SANTEN PHARMACEUTICAL CO revenue for the last year amounted to 301.96 B JPY, the most of which — 281.02 B JPY — came from its highest performing source at the moment, Prescription Drugs, the year earlier bringing 260.24 B JPY. The greatest contribution to the revenue figure was made by Japan — last year it brought SANTEN PHARMACEUTICAL CO 175.61 B JPY, and the year before that — 177.37 B JPY.